MNMD (Mind Medicine (MindMed) Inc.): Time to Pay Attention?

The price of Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) closed at $3.56 in the last session, up 0.42% from day before closing price of $3.54. In other words, the price has increased by $+0.0150 from its previous closing price. On the day, 644156 shares were traded. MNMD stock price reached its highest trading level at $3.6950 during the session, while it also had its lowest trading level at $3.4950.

Top 5 Undervalued Stocks To Own In 2023

Microchip Maker Releases "World's Most Powerful Data Center CPU". It could allow the company who manufactures it to lead the industry as the global microchip shortage continues into the coming year. We've put together a free research report that explains all the details. Not only will you find out why analysts believe this chip manufacturer could lead the pack, you will also discover four more potential winners for the coming year.

Click here to download your Free Research Report…

Sponsored

Ratios:

We take a closer look at MNMD’s different ratios to gain a better understanding of the stock.

Upgrades & Downgrades

On November 16, 2022, RBC Capital Mkts started tracking the stock assigning a Outperform rating and target price of $5.

On August 26, 2022, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $3.50.Oppenheimer initiated its Outperform rating on August 26, 2022, with a $3.50 target price.

Insider Transactions:

An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Dec 21 when Barrow Robert sold 3,861 shares for $2.69 per share. The transaction valued at 10,386 led to the insider holds 247,232 shares of the business.

Karlin Dan sold 1,211 shares of MNMD for $3,258 on Dec 21. The Chief Medical Officer now owns 264,082 shares after completing the transaction at $2.69 per share. On Oct 27, another insider, Karlin Dan, who serves as the Chief Medical Officer of the company, sold 644 shares for $3.00 each. As a result, the insider received 1,932 and left with 265,293 shares of the company.

Stock Price History:

Over the past 52 weeks, MNMD has reached a high of $22.20, while it has fallen to a 52-week low of $2.12. The 50-Day Moving Average of the stock is 2.7333, while the 200-Day Moving Average is calculated to be 7.8986.

Shares Statistics:

According to the various share statistics, MNMD traded on average about 611.88K shares per day over the past 3-months and 776.89k shares per day over the past 10 days. A total of 37.57M shares are outstanding, with a floating share count of 32.93M. Insiders hold about 12.20% of the company’s shares, while institutions hold 14.93% stake in the company. Shares short for MNMD as of Oct 13, 2022 were 1M with a Short Ratio of 2.28M, compared to 963.78k on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 2.82% and a Short% of Float of 2.84%.

Earnings Estimates

The company has 5 analysts who recommend its stock at the moment. On average, analysts expect EPS of -$0.6 for the current quarter, with a high estimate of -$0.55 and a low estimate of -$0.63, while EPS last year was -$0.9. The consensus estimate for the next quarter is -$0.59, with high estimates of -$0.44 and low estimates of -$0.67.

Analysts are recommending an EPS of between -$0.3 and -$2.56 for the fiscal current year, implying an average EPS of -$2. EPS for the following year is -$2.42, with 6 analysts recommending between -$2.06 and -$3.